fig4

Figure 4. Immunoblot results in chronically ischemic myocardium with canagliflozin and sitagliptin. Data shown from immunoblot experiments in chronically ischemic myocardium in swine treated with canagliflozin (CANA, n = 8), sitagliptin (SIT, n = 5), and vehicle with no drug (CON, n = 8). *signifies a P value of less than 0.05.